Active substance
Results for the substance group a c w135 and y conjugated meningococcal vaccine
2 results
About this active substance
The meningococcal conjugate vaccine for groups A, C, W135, and Y is used to prevent infections caused by Neisseria meningitidis, a bacterium that can cause meningitis and septicemia. The vaccine contains capsular polysaccharides from these serogroups, linked to a carrier protein, which stimulates a stronger and longer-lasting immune response.
The vaccine is administered intramuscularly, usually in a single dose, and is recommended for adolescents, individuals traveling to endemic areas, and those at increased risk of infection, such as students living in dormitories or pilgrims traveling to high-risk regions.
Common side effects include pain at the injection site, mild fever, fatigue, and headache. In rare cases, severe allergic reactions may occur.
The meningococcal conjugate vaccine for groups A, C, W135, and Y is an essential preventive measure for reducing the incidence of meningococcal diseases and their severe complications, helping to protect public health.
The vaccine is administered intramuscularly, usually in a single dose, and is recommended for adolescents, individuals traveling to endemic areas, and those at increased risk of infection, such as students living in dormitories or pilgrims traveling to high-risk regions.
Common side effects include pain at the injection site, mild fever, fatigue, and headache. In rare cases, severe allergic reactions may occur.
The meningococcal conjugate vaccine for groups A, C, W135, and Y is an essential preventive measure for reducing the incidence of meningococcal diseases and their severe complications, helping to protect public health.